Buscar
30/11/2024
Amyloid-lowering treatment in Alzheimer's disease
Jessen, F, Frölich, L, Hort, J, Winblad, B, Fortea, J. Amyloid-lowering treatment in Alzheimer's disease. LANCET. 2024; 404(10468)DOI:10.1016/S0140-6736(24)02510-8. PMID:39551061. IF:88.500(Q1/1D).
01/11/2024
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation
Dubois, B, Villain, N, Schneider, L, Fox, N, Campbell, N, Galasko, D, Kivipelto, M, Jessen, F, Hanseeuw, B, Boada, M, Barkhof, F, Nordberg, A, Froelich, L, Waldemar, G, Frederiksen, KS, Padovani, A, Planche, V, Rowe, C, Bejanin, A, Ibanez, A, Cappa, S, Caramelli, P, Nitrini, R, Allegri, R, Slachevsky, A, de Souza, LC, Bozoki, A, Widera, E, Blennow, K, Ritchie, C, Agronin, M, Lopera, F, Delano-Wood, L, Bombois, S, Levy, R, Thambisetty, M, Georges, J, Jones, DT, Lavretsky, H, Schott, J, Gatchel, J, Swantek, S, Newhouse, P, Feldman, HH, Frisoni, GB. Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation. JAMA Neurology. 2024; 81(12)DOI:10.1001/jamaneurol.2024.3770. PMID:39483064. IF:21.300(Q1/1D).
01/11/2024
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability
Therriault, J, Janelidze, S, Benedet, AL, Ashton, NJ, Martínez, JA, Gonzalez-Escalante, A, Bellaver, B, Alcolea, D, Vrillon, A, Karim, H, Mielke, MM, Hong, CH, Roh, HW, Contador, J, Pijoan, AP, Algeciras-Schimnich, A, Vemuri, P, Graff-Radford, J, Lowe, VJ, Karikari, TK, Jonaitis, E, Brum, W, Tissot, C, Servaes, S, Rahmouni, N, Macedo, AC, Stevenson, J, Fernandez-Arias, J, Wang, YT, Woo, MS, Friese, MA, Jia, WL, Dumurgier, J, Hourregue, C, Cognat, E, Ferreira, PL, Vitali, P, Johnson, S, Pascoal, TA, Gauthier, S, Lleó, A, Paquet, C, Petersen, RC, Salmon, D, Mattsson-Carlgren, N, Palmqvist, S, Stomrud, E, Galasko, D, Son, SJ, Zetterberg, H, Fortea, J, Suárez-Calvet, M, Jack, CR, Blennow, K, Hansson, O, Rosa-Neto, P. Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability. Nature Aging. 2024; 4(11)DOI:10.1038/s43587-024-00731-y. PMID:39533113. IF:19.400(Q1/1D).
01/11/2024
Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimaging
Caillaud, M, Laisney, M, Bejanin, A, Duclos, H, Scherer-Gagou, C, Prundean, A, Bonneau, D, Eustache, F, Verny, C, Desgranges, B, Allain, P. Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimaging. Journal Of Huntingtons Disease. 2024; 13(4)DOI:10.1177/18796397241291730. PMID:39973378. IF:(Q/D).